Interactions between endogenous baboon type-C virus and oncogenic viruses. I. Syncytium induction and development of infectivity assay.
Cells releasing the endogenous baboon virus (BV) can interact with human KC cells containing the Rous sarcoma virus (RSV) genome, resulting in cell fusion and syncytium formation. This interaction has been utilized in the development of a sensitive infectivity assay for BV. The titration pattern is of a one-hit type, demonstrating a linear relationship between virus concentration and number of syncytial plaques obtained in the KC co-cultivation assay. Endpoint titration comparisons indicate that the KC test is as sensitive as the immunofluorescence or the RNA-directed DNA-polymerase assays. Attempts to develop an XC test for BV failed, indicating that while BV can interact with the RSV genome it will do so in the human KC cells and not in the rat XC cells. Syncytia are also induced when KC cells are directly exposed to cell-free BV; however, a linear dose relationship is not obtained. When syncytium-positive KC cultures are passaged, the syncytia disappear and a chronic BV infection is established. These KC-BV cells then lose the ability to interact with either the endogenous cat RD-114 virus or the Mason-Pfizer virus which are known to form syncytia with KC cells.
D000818:Animals; D000956:Antigens, Viral; D001358:Avian Sarcoma Viruses / Q000276:immunology / Q000472:pathogenicity*; D002459:Cell Fusion; D002460:Cell Line; D006801:Humans; D007106:Immune Sera; D007181:Inclusion Bodies, Viral; D009500:Neutralization Tests; D010215:Papio / Q000382:microbiology*; D012190:Retroviridae / Q000276:immunology / Q000472:pathogenicity*; D014776:Virus Cultivation
D000956:Antigens, Viral; D007106:Immune Sera